Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Apparatus and method for multiplying frequency of a clock signal
Hybrid fiber constructions to mitigate creep in composites
Monitoring heap in real-time by a mobile agent to assess performance of virtual machine
Restarting event and alert analysis after a shutdown in a distributed processing system
Probiotic Bifidobacterium strains
Local call local switching at handover
Quinazoline compounds and their use in perfume compositions
  Randomly Featured Patents
Discharge tube
Walking assistance device
Structural units adaptable to preexisting chassis and vehicle assembled therefrom
Method for injection molding a curvilinear lens
Industrial truck with force-transmitting door with double hinge
Method and apparatus for removing a bearing
Surface protecting film for polycarbonate
Internal memory in application specific integrated circuit device and method for testing internal memory
Television broadcast receiver
Quantizer selection based on region complexities derived using a rate distortion model